Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold promise in fighting COVID-19, a respiratory disease caused by the SARS-CoV-2 coronavirus, according to a new modeling study from the University of Texas Southwestern Medical Center. This scanning electron microscope image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. The virus shown was isolated from a patient in...
